Skip to main content
SpringerLink
Log in

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: a comprehensive review. Cancer. 2018;124(4):667–78. https://doi.org/10.1002/cncr.31196.

    Article  PubMed  Google Scholar 

  2. Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6(12):915–24. https://doi.org/10.1016/S2213-2600(18)30411-9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cao C, Gupta S, Chandrakumar D, Tian DH, Black D, Yan TD. Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer. Ann Cardiothorac Surg. 2014;3(2):134–41. https://doi.org/10.3978/j.issn.2225-319X.2014.03.08.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27(20):3290–6. https://doi.org/10.1200/JCO.2008.21.5681.

    Article  PubMed  Google Scholar 

  5. Timmerman RD, Paulus R, Pass HI, et al. Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG Oncology RTOG 0618 Trial. JAMA Oncol. 2018;4(9):1263–6. https://doi.org/10.1001/jamaoncol.2018.1251.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wu J, Bai HX, Chan L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study. J Thorac Cardiovasc Surg. 2020;160(5):1350-7.e11. https://doi.org/10.1016/j.jtcvs.2019.11.132.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology Program, National Cancer Institute, NationalInstitutesofHealth, Building 10, Room 4-3740, Bethesda, MD, 20892, USA

    Martha E. Teke MD, Amber Leila Sarvestani MD & Jonathan M. Hernandez MD

  2. Division of Thoracic Surgery, Department of Thoracic and Cardiovascular Surgery, Allegheny Health Network, Pittsburgh, PA, USA

    Hiran C. Fernando MD

  3. Department of Radiation Oncology, University of Texas Southwestern Medical Center, 2280 Inwood Rd., Dallas, TX, USA

    Robert D. Timmerman MD

Authors
  1. Martha E. Teke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amber Leila Sarvestani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiran C. Fernando MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert D. Timmerman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jonathan M. Hernandez MD or Robert D. Timmerman MD.

Ethics declarations

The authors declare they have no conflicts of interest and nothing to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 161 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teke, M.E., Sarvestani, A.L., Hernandez, J.M. et al. A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC). Ann Surg Oncol 29, 4686–4687 (2022). https://doi.org/10.1245/s10434-022-11584-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11584-3

Search

Navigation